Diagnostics Discovery Laboratory

Core technologies: The DDL has strengths in several technologies that are available for use by the private sector, particularly firms located in Northern Nevada. These technologies are listed in the core technology portion of this website. Inquiries regarding use of core technologies should be directed to Dr. David AuCoin. Technology transfer: Licensing of technology is an integral component of the mission of the Diagnostics Discovery Laboratory. Under the auspices of the UNR Enterprise & Innovation Office, the DDL has licensed several monoclonal antibodies for use in diagnostics development. In addition, the DDL has an expanding portfolio of intellectual property that is available for licensing. We invite inquires regarding both existing technologies and potential partnerships in developing new diagnostics. Our strengths are in identification of targets for diagnostic immunoassays and production of monoclonal antibodies for assay construction.

Initial inquiries may be directed to Dr. David AuCoin. Further inquiries regarding licensing of technology or collaboration in technology development should be directed to Ellen Purpus. Additional information regarding technology transfer at the University of Nevada, Reno can be found at the UNR Enterprise & Innovation website.

Ellen Purpus
Assistant Vice President, Enterprise & Innovation